Mojgan Reza

Newcastle Upon Tyne, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1.

GATA2 deficiency phenotype associated with tandem duplication of GATA2 and overexpression of GATA2-AS1.

Journal: Blood advances
Published: May 19, 2021

Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy.

Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy.

Journal: Journal of neuromuscular diseases
Published: May 12, 2020

RUNX1/RUNX1T1 mediates alternative splicing and reorganises the transcriptional landscape in leukemia.

RUNX1/RUNX1T1 mediates alternative splicing and reorganises the transcriptional landscape in leukemia.

Journal: Nature communications
Published: August 21, 2019

Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy.

Tumor Necrosis Factor Receptor SF10A (TNFRSF10A) SNPs Correlate With Corticosteroid Response in Duchenne Muscular Dystrophy.

Journal: Frontiers in genetics
Published: June 30, 2019

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.

Journal: Cancer cell
Published: April 17, 2019

TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy.

TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy.

Journal: European journal of human genetics : EJHG
Published: November 14, 2018

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.

The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation.

Journal: Cancer cell
Published: November 29, 2017

MRC Centre Neuromuscular Biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwide.

MRC Centre Neuromuscular Biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwide.

Journal: Neuromuscular disorders : NMD
Published: February 14, 2017

Optimization of Internally Deleted Dystrophin Constructs.

Optimization of Internally Deleted Dystrophin Constructs.

Journal: Human gene therapy methods
Published: August 02, 2016

Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy.

Autologous skeletal muscle derived cells expressing a novel functional dystrophin provide a potential therapy for Duchenne Muscular Dystrophy.

Journal: Scientific reports
Published: September 22, 2015

The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases.

The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases.

Journal: European journal of human genetics : EJHG
Published: August 11, 2014

EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia.

EXOSC8 mutations alter mRNA metabolism and cause hypomyelination with spinal muscular atrophy and cerebellar hypoplasia.

Journal: Nature communications
Published: February 12, 2014
Showing 1-12 of 14

Last Updated: 09/26/2026